In this report, we present the largest case series of patients developing AK and/or cutaneous SCC during therapy with sorafenib. The mechanism through which sorafenib may be implicated in the ...

While most skin cancer arises as a brand new spot, some squamous cell carcinoma develops from a precancer called actinic keratosis, or solar keratosis (usually a rough, flat, pink spot on the skin, ...

Actinic keratoses do not turn into melanoma. Actinic keratoses can turn into squamous cells, but possibly basal cells. Melanomas don't arise from actinic keratoses, because melanomas arise from ...

Opens in a new tab or window Use of immune checkpoint inhibitors for cancer was associated with a significant reduction in actinic keratoses ... of cutaneous squamous cell carcinomas (cSCCs ...

Australia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma ...

With actinic keratosis (AK ... Early diagnosis and treatment are imperative, as around 60% of squamous cell carcinoma (SCC) cases – one of the most common forms of skin cancer – start out ...

Biofrontera announced the enrollment of the final patient in its Phase 3 clinical trial evaluating Ameluz for the treatment of mild to moderate ...

Two patients reported a history of previous treatment for AK and SCC before the initiation of sorafenib, and 1 patient had been previously treated for basal cell carcinoma. Ten of the 14 patients ...